Haematology 3: Haemostasis And Bleeding Disorders Flashcards

1
Q

List 4 Pro-coagulant factors in the body?

A

Platelets
vWF
Endothelium
Coagulation cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List 4 Anti-coagulant factors in the body ?

A

AT (antithrombin)
Protein S + Protein C
TFPI (Tissue factor pathway inhibitor)
Fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List 2 thrombopoietic factors ?

A

Thrombopoietin
IL-6
IL-12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which Surface glycoprotein do platelets use to bind to vWF ?

A

GpIb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which glycoprotein do platelets use to bind directly to collagen ?

A

GpIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which glycoproteins do platelets use to bind to other platelets when aggregating ?

A

GpIIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which 2 mediators do platelets release when they bind to subendothelial structures (vWF or collagen) to cause platelet aggregation ?

A

ADP

Thromboxane A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does Aspirin inhibit platelet aggregation?

A

aspiring irreversibly Inhibits Cyclo-oxygenase (COX)
This prevents Arachidonic acid being converted to endoperoxides
This prevents formation of thromboxane A2
Less Thromboxane A2 means less platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List 2 drug targets for inhibiting platelet aggregation ?

A

Thromboxane A2 production - Aspirin

ADP receptors - Clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which pathway is more important for coagulation in the human body ?

A) Intrinsic pathway
B) Extrinsic pathway
C) Contact activation pathway

A

B) extrinsic pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the sequence of events in the Initiation phase of the Clotting cascade ?

A

1) Damage to endothelium causes TF to be exposed
2) Factor VII binds to TF and becomes activated to FVIIa
3) FVIIa/TF complex activate FIX and FX to FIXa and FXa
4) FXa binds to FVa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the sequence of events in the activation phase of the clotting cascade ?

A

1) FXa/FVa complex converts prothrombin to thrombin
2) Thrombin activates FVIII, FXI and recruits more FVa
3) FXIa activates FIX to FIXa
4) Activated platelet binds FVa, FVIIIa and FIXa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the sequence of events in the propagation phase of the clotting cascade ?

A

1) FVIIIa/ FIXa complex on platelets activates FXa on the surface of the platelet.
2) FXa and FVa cause a “thrombin burst” where loads of Prothrombin is converted to Thrombin
3) Thrombin converts fibrinogen to fibrin
4) Fibrin is cross linked to form a stable fibrin clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which 4 clotting factors are vitamin K dependent ?

A

10
9
7
2

Think 1972

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the role of tPA (tissue plasminogen activator) ?

A
  • Converts plasminogen to plasmin
  • Plasmin cleaves The fibrin clot

tPA is produced by the endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which of these molecules does not promote Plasminogen conversion to Plasmin ?

A) tPA
B) Urokinase 
C) FXIIa
D) FXIa 
E) PAI 1
A

E) PAI1

Plasminogen activator inhibitor inhibits Plasminogen conversion to Plasmin by inhibiting Urokinase and tPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does TAFI do ?

A

TAFI (thrombin Activated Fibrinolysis inhibitor) is a Thrombin dependent inhibitor of Fibrin breakdown

18
Q

Deficiency of which component is the most Thrombogenic ?

A) TAFI
B) FVIIIa
C) AT3
D) vWF 
E) Protein S
A

C) AT3

Deficiency of Antithrombin (AT) is very rare but is the most thrombogenic

19
Q

What is the role of Protein C and protein S ?

A

Inhibit FVIIIa and FVa

20
Q

What is the role of Thrombomodulin ?

A

Thrombomodulin is an endothelial receptor for Protein C
It first needs to be activated by Thrombin.
EPCR is another receptor which helps Thrombomodulin bind to protein C

When Thrombomodulin binds to Thrombin and Protein C the complex is called APC (activated protein C)

21
Q

What is the role of APC (activated protein C) ?

A

APC inactivates FVa and FVIIIa

Requires protein S as cofactor

22
Q

What is different in the interaction between APC and FVa in people with Factor V Leiden ?

A

People with Factor V Leiden have APC resistance.

This means activated factor V is not inactivated by APC.

23
Q

What is the physiological role of TFPI as an anticoagulant ?

A

TFPI neutralises the TF/FVIIa complex.

TFPI is produced as a result of TF/FVIIa complex formation in order to stop activation by the extrinsic pathway. (TF/FVIIa is only required for a very short time to activate FX and FIX)

24
Q

What disease is associated with large platelets ?

A

grey platelet syndrome

25
Q

What is ITP (immune thrombocytopenia purpura) ?

A

Autoantibodies against platelets

This causes the platelets to b e removed and destroyed by the immune system

26
Q

List 2 common inherited disorders of coagulation (bleeding disorders) ?

A

Haemophilia A / B

Von willibrand disease

27
Q

Which coagulation factors are deficient in:

Haemophilia A
Haemophilia B

A

Haemophilia A - Factor 8

Haemophilia B - Factor 9

28
Q

What is the inheritance pattern of haemophilia A /B ?

A

X-linked

29
Q

What happens to APTT and PT in Haemophilia A/B ?

A

APTT - INCREASED
PT- normal

APTT Is a measure of the intrinsic pathway

30
Q

List 3 clinical features of haemophilia A/B ?

A

Haemarthroses (bleeding into joints)
Prolonged bleeding after surgery
Ecchymoses

31
Q

How is vWD inherited ?

A

Autosomal dominant

32
Q

What are the differences in type1, type 2 and type 3 vWD ?

A

Type 1- partial quantitative defficiency in vWF
Type 2- Partial Qualitative decency in vWF
Type 3- Complete quantitative deficiency in vWF

33
Q

How does most of vWF circulate in the blood ?

A

Most of it is bound to factor 8

34
Q

What happens to APTT, PT, TT and fibrinogen in DIC ?

A

APTT- prolonged
PT- prolonged
TT- prolonged
Fibrinogen- decreased

35
Q

What are 3 treatments of Vitamin K deficiency ?

A

I.V Vitamin K
FFP
PCC (Prothrombin complex concentrate) Vit K dependent coagulation factors

36
Q

List 3 differences in clinical presentation of Coagulation and platelet disorders ?

A

Platelet disorders

  • Superficial bleeding (petechia)
  • mucous membrane bleeding
  • bleeding immediately after surgery

Coagulation disorders

  • Deep bleeding into Joints (haemarthroses)/muscles
  • delayed bleeding after surgery/trauma
  • no prolonged bleeding after cuts
37
Q

List 2 congenital causes of Vascular defects of coagulation ?

A

Older-Weber-rendu syndrome

Ehler’s danlos syndrome

38
Q

List 3 acquired vascular defects of coagulation ?

A

Dengue haemorrhagic fever
Scurvy
Meningococcal infection

39
Q

What is the treatment of Haemophilia A / B ?

A

Factor 8 / 9 concentrates replacement therapy

40
Q

Which drug is used in the treatment of Haemophilia A ?

A

Desmopressin (causers increased vWF release from the endothelium. vWF is a factor VIII carrier)

41
Q

Name 1 carrier protein of Factor VIII ?

A

vWF

42
Q

Describe how you can used Ristocetin to test for vWD ?

A

Add Ristocetin to the patients vWF and platelets in a test tube. Ristocetin normally causes vWF to find to Gp1b on platelets causing platelet aggregation. If there is no platelet aggregation then this means there is a qualitative defect in vWF or Gp1b (Bernard soulier syndrome).